ArticleJournal of experimental & clinical cancer research : CR2022

Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.

Li Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.